Taevas
ThailandFood & Dietary Supplements
Product Registration
Market Access for Product-Registration in Thailand
Navigating the intricate global regulatory and commercial landscapes is critical for successful product registration. Taevas Life Sciences provides comprehensive market access strategies to ensure your life science product achieves optimal entry and susta
Market
Global
Industry
Product-Registration
Regulator
Multiple Global Regulatory Bodies (e.g., FDA, EMA, PMDA, NMPA)
Timeline
8-12 weeks (for strategic development)
Deliverables
Global Market Access Strategy Report, Reimbursement Roadmap, Value Dossier Framework
What We Deliver
6 Pillars of Market Access for Global Product Registration
Every engagement covers a structured set of pillars — each customised to your specific category, target segment, and strategic questions.
01
Global Regulatory Intelligence & Strategy
Our experts provide in-depth analysis of diverse international regulatory requirements, ensuring your product registration strategy is compliant and optimized for accelerated approval across key markets. We identify potential hurdles and define clear pathways.
Multi-jurisdictional Regulatory Landscape Analysis
Strategic Roadmap for Product Registration
How It Works
How It Works: Our Global Market Access Process
A structured engagement — typically delivered in a few weeks.
Step 1 · Week 1-2
Initial Assessment & Scoping
We begin with a comprehensive analysis of your product, target markets, and existing data to define the scope and specific challenges for global product registration and market access. This foundational step ensures alignment with your strategic objectives.
Market Snapshot
Market Overview: Global Product Registration & Market Access
Increasing Complexity of Global Regulations
The landscape of global product registration is continuously evolving, with each market presenting unique regulatory requirements, HTA processes, and reimbursement criteria. Navigating these complexities demands specialized expertise and strategic foresight to avoid delays.
The Imperative of Value Demonstration
Global payers increasingly demand robust evidence of clinical effectiveness and economic value beyond basic efficacy. A comprehensive market access strategy must integrate HEOR and real-world evidence to secure favorable reimbursement and broad patient access.
What's Included
Deliverables
A structured, decision-ready package of deliverables.
Global Market Access Strategy Report
A detailed report outlining regulatory pathways, HEOR strategy, pricing recommendations, and payer engagement plans for target global markets.
Payer Landscape & Reimbursement Roadmap
An in-depth analysis of key payer archetypes and reimbursement systems in target countries, with a clear roadmap for securing optimal access.
Core Value Dossier Framework
A customizable framework for your product's value story, designed for adaptation to specific regional HTA and payer requirements.
Regulatory Pathway & Submission Guide
Comprehensive guidance on navigating specific regulatory submission processes and requirements across major global jurisdictions.
Who This Is For
Use Cases
Orphan Drug
Accelerating Orphan Drug Access in EU & US
A biotech company sought to launch a novel orphan drug simultaneously in the European Union and United States. Taevas Life Sciences developed a harmonized global regulatory and market access strategy, leveraging parallel submission pathways and targeted HEOR to demonstrate value to both EMA and FDA, alongside key European HTA bodies.
Outcome
Achieved concurrent regulatory approval and favorable reimbursement decisions in multiple key markets, significantly reducing time-to-market.
Next Steps
Related Services
FAQ
Frequently Asked Questions
Get Started
Ready to Start Market Access in Global?
Unlock the full potential of your life science product on the global stage. Partner with Taevas Life Sciences to navigate complexities and achieve successful market entry worldwide.
Access Global Regulatory Expertise
Optimize Pricing & Reimbursement
Accelerate Time-to-Market
Maximize Product Value